Evolus (EOLS) Interest Coverage Ratio Growth (3y) (2020 - 2026)
Evolus (EOLS) Interest Coverage Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn | 38.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.81% |
| Mar 31, 2026 | 10.03% |
| Dec 31, 2025 | 31.28% |
| Sep 30, 2025 | 12.66% |
| Jun 30, 2025 | 14.64% |
| Mar 31, 2025 | -48.69% |
| Dec 31, 2024 | -26.65% |
| Sep 30, 2024 | -450.76% |
| Jun 30, 2024 | -5.60% |
| Mar 31, 2024 | -69.21% |
| Dec 31, 2023 | -27.99% |
| Sep 30, 2023 | 9.63% |
| Jun 30, 2023 | 9.41% |
| Mar 31, 2023 | 20.34% |
| Dec 31, 2022 | -43.10% |
| Sep 30, 2022 | -35.49% |
| Jun 30, 2022 | 21.56% |
| Mar 31, 2022 | -21.91% |
| Sep 30, 2021 | 95.00% |
| Jun 30, 2021 | 81.43% |